BIOTELEMETRY, INC.|4Oct 2, 4:23 PM ET

Broadway Fred 4

4 · BIOTELEMETRY, INC. · Filed Oct 2, 2018

Form 4

Period: 2018-09-28

SVP - Sales Marketing

Transactions

Exercise/Conversion
Common Stock
2018-09-28$2.54/sh+23,912$60,736→ 114,993 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-09-28−26,963→ 0 total
Exercise: $2.80Exp: 2022-02-21→ Common Stock (26,963 underlying)
Exercise/Conversion
Common Stock
2018-09-28$4.67/sh+39,238$183,241→ 64,118 total
Exercise/Conversion
Common Stock
2018-09-28$2.80/sh+26,963$75,496→ 91,081 total
Sale
Common Stock
2018-09-28$65.00/sh−90,113$5,857,345→ 24,880 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-09-28−39,238→ 0 total
Exercise: $4.67Exp: 2021-03-04→ Common Stock (39,238 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2018-09-28−23,912→ 0 total
Exercise: $2.54Exp: 2023-02-19→ Common Stock (23,912 underlying)

Footnotes (4)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018.
[F2]The options were fully exercisable on December 31, 2014.
[F3]The options were fully exercisable on December 31, 2015.
[F4]The options were fully exercisable on February 19, 2017.

Documents

1 file